Metabolism and transport of drugs and xenobiotics
Research group
01.01.2010 -
School of Pharmacy, Faculty of Health Sciences
Leaders
Individuals are continuously exposed to myriad of foreign compounds derived from the diet, environmental pollutants and drugs (xenobiotics). Metabolic enzymes in the body usually convert xenobiotics to more water-soluble and less harmful metabolites although enzymatic reactions may also produce reactive, toxic products. Transport proteins aid in transfer of xenobiotics and their metabolites across cell membranes and excrete them out of the body. Exposure to xenobiotics can either block the activity of metabolic enzymes and transporters (inhibition) or enhance their expression levels (induction).
Projects
Keywords
Leaders
Professors
-
Paavo Honkakoski
ProfessorSchool of Pharmacy, Faculty of Health Sciences -
Risto Juvonen
Senior ResearcherSchool of Pharmacy, Faculty of Health Sciences -
Hannu Raunio
Professor, EmeritusSchool of Pharmacy, Faculty of Health Sciences
Senior Researchers
Doctoral Researchers
Technicians
Publications
14 items-
Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues
Hammid, Anam; Fallon, John K; Lassila, Toni; Salluce, Giulia; Smith, Philip C; Tolonen, Ari; Sauer, Achim; Urtti, Arto; Honkakoski, Paavo. 2021. Molecular pharmaceutics. 18: 1305-1316 -
Coumarin-Based Profluorescent and Fluorescent Substrates for Determining Xenobiotic-Metabolizing Enzyme Activities In Vitro
Raunio, Hannu; Pentikäinen, Olli; Juvonen, Risto O. 2020. International journal of molecular sciences. 21: E4708 -
Inhibition of Human CYP1 Enzymes by a Classical Inhibitor α-Naphthoflavone and a Novel Inhibitor N-(3, 5- Dichlorophenyl)cyclopropanecarboxamide - An in Vitro and in Silico Study
Juvonen, RO; Jokinen, EM; Javaid, A; Lehtonen, M; Raunio, H; Pentikäinen, OT. 2020. Chemical biology and drug design. 95: 520-533 -
Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR
Küblbeck, Jenni; Niskanen, Jonna; Honkakoski, Paavo. 2020. Cells. 9: 2306 -
Functional impact of cytochrome P450 3A (CYP3A) missense variants in cattle
Giantin, M; Rahnasto-Rilla, M; Tolosi, R; Lucatello, L; Pauletto, M; Guerra, G; Pezzato, F; Lopparelli, RM; Merlanti, R; Carnier, P; Capolongo, F; Honkakoski, P; Dacasto, M. 2019. Scientific reports. 9: 19672 -
In vitro glucuronidation of 7-hydroxycoumarin derivatives in intestine and liver microsomes of Beagle dogs
Juvonen, Risto O; Heikkinen, Aki T; Kärkkäinen, Olli; Jehangir, Rabia; Huuskonen, Juhani; Troberg, Johanna; Raunio, Hannu; Pentikäinen, Olli T; Finel, Moshe. 2019. European journal of pharmaceutical sciences. 141: 105118 -
Metabolism of Scoparone in Experimental Animals and Humans
Juvonen, RO; Novák, F; Emmanouilidou, E; Auriola, S; Timonen, J; Heikkinen, AT; Küblbeck, J; Finel, M; Raunio, H. 2019. Planta medica. 85: 453-464 -
Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions
Kang, HE; Malinen, MM; Saran, C; Honkakoski, P; Brouwer, KLR. 2019. Drug metabolism and disposition. 47: 1222-1230 -
The basis for strain-dependent rat aldehyde dehydrogenase 1A7 (ALDH1A7) gene expression
Touloupi, K; Kublbeck, J; Magklara, A; Molnar, F; Reinisalo, M; Konstandi, M; Honkakoski, P; Pappas, P. 2019. Molecular pharmacology. 96: 655-663 -
Development of New Coumarin-Based Profluorescent Substrates for Human Cytochrome P450 Enzymes
Juvonen, Risto O; Ahinko, Mira; Huuskonen, Juhani; Raunio, Hannu; Pentikäinen, Olli T. 2018. Xenobiotica. 49: 1015-1024